Suchergebnisse - "Kaelber, David C"

PubPharm (5)

1

Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations : a retrospective cohort study

enthalten in: Molecular psychiatry | 2024

von Wang, W. | Volkow, N. | Berger, N. | +3

2

Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020-2022

enthalten in: Molecular psychiatry | 2024

von Wang, C. | Kohli, R. | Olaker, V. | +4

3

Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US

enthalten in: Molecular psychiatry | 2023

von Wang, L. | Volkow, N. | Berger, N. | +3

CommentIn: Mol Psychiatry. 2023 Feb;28(2):541-542. - PMID 36550196

4

Correction : COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

enthalten in: Molecular psychiatry | 2021

von Wang, Q. | Kaelber, D. | Xu, R. | +1

ErratumFor: Mol Psychiatry. 2021 Jan;26(1):30-39. - PMID 32929211

5

COVID-19 risk and outcomes in patients with substance use disorders : analyses from electronic health records in the United States

enthalten in: Molecular psychiatry | 2021

von Wang, Q. | Kaelber, D. | Xu, R. | +1

ErratumIn: Mol Psychiatry. 2020 Sep 30;:. - PMID 32999436

1
[1]